Citadel Advisors »

Denali Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 77k 21.46
2023-09-30 $1.6M 76k 20.63
2023-06-30 $2.0M 67k 29.51
2023-03-31 $33M 1.4M 23.04
2022-12-31 $1.9M 69k 27.81
2022-06-30 $9.8M 332k 29.43
2022-03-31 $25M 761k 32.19
2021-12-31 $24M 538k 44.60
2021-09-30 $5.2M 104k 50.46
2021-06-30 $2.6M 33k 78.44
2021-03-31 $16M 276k 57.11
2020-12-31 $4.4M 53k 83.77
2020-09-30 $8.6M 240k 35.84
2020-06-30 $2.3M 111k 21.05
2020-03-31 $1.5M 85k 17.51
2019-12-31 $1.2M 67k 17.40
2019-09-30 $1.5M 100k 15.25
2019-06-30 $4.0M 195k 20.72
2019-03-31 $645k 28k 23.23
2018-06-30 $752k 49k 15.22